Principal Quantitative Scientist
Roche
Summary
Roche Diagnostics has built a new strategic area – Roche Information Solutions (RIS) - charged with creating a modern portfolio of decision support software products and generating insights that change the way patients are cared for. Our challenge is to bring together complex diagnostic and treatment data from medical devices and IT systems and intelligently process and present this data to clinicians, researchers, and caregivers to improve research outcomes and patient care by offering a suite of Clinical Decision Support (CDS) solutions.
Job description
The Position
Roche Diagnostics has built a new strategic area – Roche Information Solutions (RIS) - charged with creating a modern portfolio of decision support software products and generating insights that change the way patients are cared for. Our challenge is to bring together complex diagnostic and treatment data from medical devices and IT systems and intelligently process and present this data to clinicians, researchers, and caregivers to improve research outcomes and patient care by offering a suite of Clinical Decision Support (CDS) solutions.
This role requires 3 days of being on-site in Indianapolis.
The Opportunity
As a Senior Principal Quantitative Scientist, you will act as a leading scientific authority for Real-World Data (RWD), driving evidence generation that fundamentally shapes the development and adoption of our digital health, and IVD portfolio. This is a high-impact, independent, and externally facing role requiring scientific leadership, deep expertise, and the ability to influence critical business, regulatory, and long-term strategic decisions. Your work will involve leveraging diverse data types, including EHR, claims, omics, and digital health data.
Key Responsibilities Include:
RWD Strategy & Execution (End-to-End Leadership)
- Drive the conceptualization, planning, execution, and reporting of complex, advanced RWD studies using various research and commercial healthcare databases.
- Develop RWD study protocols and independently lead complex analyses to support the evidence needs of the IVD and digital health portfolio, across multiple therapeutic areas.
- Ensure the design, execution, and presentation of RWE adhere to the highest scientific and methodological standards.
Strategic Influence & Adoption (Thought Leadership)
- Act as the go-to RWD leader, working closely with cross-functional stakeholders such as Product Leads and Medical Affairs to ensure RWD projects directly support commercial, market access, and regulatory needs.
- Champion RWD's use to supplement clinical evidence and actively identify and drive implementation of opportunities where RWD can serve as the primary evidence mechanism to achieve regulatory and reimbursement objectives.
- Represent Roche as a recognized subject matter expert with external partners (KOLs, academic institutions, healthcare authorities), leading joint publications on study design and fostering strong relationships to explore new data assets and analytical methodologies.
Expertise & Mentorship
- Serve as the internal authority on RWD sources, epidemiology, and state-of-the-art methodologies, setting best practices for the entire RWD function.
- Proactively drive innovation by defining and implementing enhanced ways of working (processes, methods, technology) and proactively sharing learnings with peers.
- Routinely mentor junior colleagues and act as an influential subject matter expert across the organization.
Who You Are
- You hold a PhD (preferred) OR Master’s Degree in a Quantitative Science field (e.g. Pharmacoepidemiology, Epidemiology, RWD Biostatistics, Pharmacoeconomics, Health Economic and Outcomes Research, or related).
- 7+ years of directly related (industry, consulting, or other relevant) experience, demonstrating increasing levels of responsibility and independent scientific leadership.
- Exceptional track record of utilizing RWD to support successful and complex regulatory submissions.
- Deep mastery of epidemiology and causal inference methodologies is required, including expertise in debating and defending methods to external regulatory and HTA bodies.
- Strong programming experience with R, Python, SQL and/or other quantitative software.
- Strong experience in using diverse RWD sources to generate insights and evidence.
Additional Skills:
- Expertise in RWD & Epidemiology: Proven hands-on experience in designing, implementing, and reporting high-impact RWD studies, with recognized expertise in advanced epidemiology and a passion for making a difference in healthcare.
- Strategic & Regulatory Acumen: A comprehensive and forward-looking understanding of regulatory guidelines and an ability to use RWD to proactively influence national and international reimbursement and clinical guidelines.
- Project & People Leadership: Demonstrated ability to lead projects of significant scope and complexity. You are a recognized team leader with experience mentoring and guiding senior team members and possess a resilient, can-do attitude.
- Communication & Collaboration: Excellent communication and collaboration skills, including the proven ability to negotiate and influence senior leaders across the organization and with external stakeholders without formal authority.
- Problem-Solving & Mindset: A data-savvy, creative, and resilient problem solver with a sense of enterprise-wide ownership and attention to detail. You are eager to learn and expand your scientific expertise as a dependable team player and critical thought partner.
Must be willing to work onsite in Indianapolis. Relocation benefits are not available for this position.
Requirements
- PhD (preferred) or Master’s Degree in a Quantitative Science field (e.g. Pharmacoepidemiology, Epidemiology, RWD Biostatistics, Pharmacoeconomics, Health Economic and Outcomes Research, or related)
- 7+ years of directly related (industry, consulting, or other relevant) experience
- Exceptional track record of utilizing RWD to support successful and complex regulatory submissions
- Deep mastery of epidemiology and causal inference methodologies
- Expertise in debating and defending methods to external regulatory and HTA bodies
- Strong programming experience with R, Python, SQL and/or other quantitative software
- Strong experience in using diverse RWD sources to generate insights and evidence
- Proven hands-on experience in designing, implementing, and reporting high-impact RWD studies
- Comprehensive understanding of regulatory guidelines
- Ability to use RWD to influence reimbursement and clinical guidelines
- Demonstrated ability to lead projects of significant scope and complexity
- Experience mentoring and guiding senior team members
- Excellent communication and collaboration skills
- Ability to negotiate and influence senior leaders and external stakeholders without formal authority
- Data-savvy, creative, resilient problem solver with attention to detail
- Must be willing to work onsite in Indianapolis
Benefits
- Discretionary annual bonus
- Benefits package
Company overview
Roche is a Swiss multinational healthcare company and a global pioneer in pharmaceuticals and diagnostics, founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotech company and the fifth-largest pharmaceutical company by revenue, Roche operates through two primary divisions: Pharmaceuticals and Diagnostics. The company is renowned for its leadership in personalized healthcare, combining strengths in both drug development and diagnostic testing to deliver tailored treatments for patients. Roche maintains a strong focus on oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders, with a portfolio that includes over 30 medicines on the World Health Organization's Model Lists of Essential Medicines. The company owns significant subsidiaries including Genentech, Chugai Pharmaceuticals, Ventana Medical Systems, and Foundation Medicine. With approximately 103,000 employees worldwide and operations in over 100 countries, Roche has established itself as a leader in cancer treatments globally while maintaining a robust pipeline of innovative therapies and diagnostic solutions. The company's commitment to sustainability has been recognized through ten consecutive years as Group Leader in the Dow Jones Sustainability Indices within the Pharmaceuticals, Biotechnology & Life Sciences Industry.